Steris (STE) Income from Non-Controlling Interests (2018 - 2026)
Steris (STE) recorded quarterly Income from Non-Controlling Interests of $100000.0 in Q1 2026, down 93.33% quarter-over-quarter from $1.5 million in Q4 2025, and down 75.0% on a YoY basis from $400000.0 in Q1 2025.
Steris (STE) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
Steris' Income from Non-Controlling Interests history runs 9 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 75.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $2.8 million (up 100.0% YoY), while the FY2026 annual figure was $2.8 million, up 100.0% from the prior year.
- Income from Non-Controlling Interests was $100000.0 for Q1 2026 at Steris, down from $1.5 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $1.5 million in Q4 2025 to a low of -$507000.0 in Q2 2022.
- Historically, Income from Non-Controlling Interests has averaged $269117.6 across 5 years, with a median of $202000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Income from Non-Controlling Interests slumped 433.68% in 2022, then soared 1801.85% in 2023.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$503000.0 in 2022, then jumped by 140.16% to $202000.0 in 2023, then tumbled by 199.01% to -$200000.0 in 2024, then surged by 850.0% to $1.5 million in 2025, then sank by 93.33% to $100000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at $100000.0 (Q1 2026), $1.5 million (Q4 2025), and $600000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 100,000.00 |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 236,000.00 |
| Mar 31, 2023 | -261,000.00 |
| Dec 31, 2022 | -503,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Jun 30, 2022 | -507,000.00 |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | -529,000.00 |
| Sep 30, 2021 | -186,000.00 |
| Jun 30, 2021 | -95,000.00 |